desipramine has been researched along with albuterol in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (36.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 7 (28.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Fawcett, JP; Gard, PR; Kerr, KP | 1 |
| Greenshaw, AJ; McManus, DJ; Mousseau, DD; Paetsch, PR; Wishart, TB | 1 |
| Antunes-Rodrigues, J; Cobas, C; de-Castro-e-Silva, E; Machado, A; Midlej, M; Ramalho, MJ | 1 |
| Rommelspacher, H; Widjaja, S; Wolffgramm, J | 1 |
| McElroy, JF; O'Donnell, JM | 1 |
| Martin, P; Simon, P; Soubrie, P | 1 |
| Hilakivi, I; Hilakivi, LA; Loikas, P; Taira, T | 1 |
| Handley, SL; Singh, L | 1 |
| Stahl, SM | 1 |
| Dooley, DJ; Hauser, KL | 1 |
| Mogilnicka, E | 1 |
| Beek, D; Kenakin, TP | 1 |
| de la Lande, IS; Ivar, PM; Marino, V; Parker, DA | 1 |
| Akers, WS; Cassis, LA | 1 |
| Horinouchi, T; Koike, K; Michikawa, H; Tanaka, Y; Yamashita, Y | 1 |
2 review(s) available for desipramine and albuterol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.
Topics: Albuterol; Antidepressive Agents; Clenbuterol; Depressive Disorder; Desipramine; Humans; Models, Molecular; Norepinephrine; Psychiatric Status Rating Scales; Receptors, Adrenergic; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin | 1984 |
23 other study(ies) available for desipramine and albuterol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Reduction of salbutamol-induced drinking by putative and proven antidepressants.
Topics: Albuterol; Animals; Antidepressive Agents; Clenbuterol; Desipramine; Drinking Behavior; Male; Rats; Receptors, Adrenergic, beta | 1991 |
Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects.
Topics: Albuterol; Animals; Antidepressive Agents; Arousal; Brain; Desipramine; Dose-Response Relationship, Drug; Imipramine; Liver; Male; Monoamine Oxidase; Motor Activity; Norepinephrine; Phenelzine; Phenethylamines; Psychotropic Drugs; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Tranylcypromine | 1991 |
Desipramine blocks stress-induced prolactin release in rats: role of central beta-2 adrenoceptors.
Topics: Albuterol; Animals; Desipramine; Injections, Intraventricular; Male; Prolactin; Rats; Rats, Inbred Strains; Restraint, Physical; Stress, Physiological | 1990 |
Effects of desipramine on rat behavior are prevented by concomitant treatment with ethanol.
Topics: 5-Hydroxytryptophan; Adenylyl Cyclases; Albuterol; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Body Temperature; Body Weight; Brain Chemistry; Cerebral Cortex; Desipramine; Ethanol; Female; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1989 |
Discriminative stimulus properties of clenbuterol: evidence for beta adrenergic involvement.
Topics: Albuterol; Amphetamine; Animals; Chlorpromazine; Clenbuterol; Desipramine; Discrimination Learning; Dose-Response Relationship, Drug; Ethanolamines; Haloperidol; Isomerism; Male; Pentylenetetrazole; Prenalterol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1988 |
Shuttle-box deficits induced by inescapable shocks in rats: reversal by the beta-adrenoreceptor stimulants clenbuterol and salbutamol.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Avoidance Learning; Clenbuterol; Clomipramine; Desipramine; Dose-Response Relationship, Drug; Electroshock; Ethanolamines; Helplessness, Learned; Male; Rats; Rats, Inbred Strains | 1986 |
Neonatal treatment with monoamine uptake inhibitors alters later response in behavioural 'despair' test to beta and GABA-B receptor agonists.
Topics: Albuterol; Animals; Animals, Newborn; Antidepressive Agents; Baclofen; Behavior, Animal; Desipramine; gamma-Aminobutyric Acid; Male; Nomifensine; Rats; Rats, Inbred Strains; Time Factors; Zimeldine | 1988 |
Chronic antidepressant treatment reduces central beta-adrenoceptor sensitivity in a behavioural test.
Topics: 5-Hydroxytryptophan; Albuterol; Animals; Antidepressive Agents; Behavior, Animal; Desipramine; Dobutamine; Drug Resistance; Drug Synergism; Iprindole; Male; Mice; Prenalterol; Receptors, Adrenergic, beta | 1986 |
Subchronic infusion of clenbuterol, a beta-adrenergic agonist, decreases the cerebellar beta receptor.
Topics: Albuterol; Animals; Cerebellum; Clenbuterol; Desipramine; Ethanolamines; Isoproterenol; Male; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1983 |
The effects of acute and repeated treatment with salbutamol, a beta-adrenoceptor agonist, on clonidine-induced hypoactivity in rats.
Topics: Albuterol; Animals; Clonidine; Desipramine; Drug Interactions; Exploratory Behavior; Fluoxetine; Imipramine; Male; Propranolol; Rats; Rats, Inbred Strains; Yohimbine | 1982 |
The measurement of antagonist potency and the importance of selective inhibition of agonist uptake processes.
Topics: Albuterol; Amitriptyline; Animals; Desipramine; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Metanephrine; Methoxamine; Models, Biological; Muscle Contraction; Muscle, Smooth; Neurons; Norepinephrine; Phentolamine; Propranolol; Rats; Rats, Inbred Strains; Receptors, Drug; Regression Analysis | 1981 |
Modulation by presynaptic beta-adrenoceptors of noradrenaline release from sympathetic nerves in human dental pulp.
Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Albuterol; Anti-Inflammatory Agents; Corticosterone; Dental Pulp; Desipramine; Electric Stimulation; Ethanolamines; Female; Humans; Isoproterenol; Male; Norepinephrine; Propranolol; Radiopharmaceuticals; Receptors, Adrenergic, beta; Receptors, Presynaptic; Sympathetic Nervous System; Sympatholytics; Sympathomimetics; Tritium; Yohimbine | 1998 |
Presynaptic modulation of sympathetic neurotransmission in rat left ventricle slices: effect of pressure overload.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic Fibers; Adrenergic Uptake Inhibitors; Albuterol; Animals; Brimonidine Tartrate; Cerebral Ventricles; Desipramine; Male; Norepinephrine; Organ Culture Techniques; Presynaptic Terminals; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Sympathomimetics; Synaptic Transmission; Tritium; Ventricular Pressure | 2000 |
Pharmacological characterization of the beta-adrenoceptor that mediates the relaxant response to noradrenaline in guinea-pig tracheal smooth muscle.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Albuterol; Animals; Atenolol; Bupranolol; Butoxamine; Desipramine; Desoxycorticosterone; Dose-Response Relationship, Drug; Female; Guinea Pigs; Histamine; Imidazoles; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Norepinephrine; Phentolamine; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Trachea | 2007 |